 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$3.87 |
$3.87 |
$3.32 |
$3.40 |
350.70K | | 04/17/2024 |
$3.40 |
$3.49 |
$3.20 |
$3.38 |
159.00K | | 04/18/2024 |
$3.37 |
$3.45 |
$3.25 |
$3.38 |
146.60K | | 04/19/2024 |
$3.34 |
$3.47 |
$3.20 |
$3.37 |
206.10K | | 04/22/2024 |
$3.29 |
$3.29 |
$2.88 |
$3.06 |
305.50K |
|
|
| Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death). | |
|
Galectin Therapeutics (GALT) has the following price history information. Looking back at GALT historical stock prices for the last five trading days, on April 16, 2024, GALT opened at $3.87, traded as high as $3.87 and as low as $3.32, and closed at $3.40. Trading volume was a total of 350.70K shares. On April 17, 2024, GALT opened at $3.40, traded as high as $3.49 and as low as $3.20, and closed at $3.38. Trading volume was a total of 159.00K shares. On April 18, 2024, GALT opened at $3.37, traded as high as $3.45 and as low as $3.25, and closed at $3.38. Trading volume was a total of 146.60K shares. On April 19, 2024, GALT opened at $3.34, traded as high as $3.47 and as low as $3.20, and closed at $3.37. Trading volume was a total of 206.10K shares. On April 22, 2024, GALT opened at $3.29, traded as high as $3.29 and as low as $2.88, and closed at $3.06. Trading volume was a total of 305.50K shares.
GALT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Galectin Therapeutics shares, starting with a $10,000 purchase of GALT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$11.99 |
|
| End price/share: |
$3.06 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-74.48% |
|
| Average Annual Total Return: |
-12.76% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,552.67 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/16/2024 | $3.40 | | 04/17/2024 | $3.38 | | 04/18/2024 | $3.38 | | 04/19/2024 | $3.37 | | 04/22/2024 | $3.06 |
|
|
Free GALT Email Alerts:
